ScreenPoint Medical demonstrates Transpara at ECR 2026
.png)
ScreenPoint Medical demonstrates Transpara at ECR 2026
Join ScreenPoint Medical at the European Congress of Radiology, March 4-7, 2026 in Vienna, Austria.
February 23, 2026
Interview: The Imaging Wire highlights MASAI findings
.png)
Interview: The Imaging Wire highlights MASAI findings
Brian Casey of The Imaging Wire interviews researcher Jessie Gommers on the latest results from the MASAI randomised controlled trial in breast cancer AI.
February 16, 2026
ScreenPoint Medical's founders honored
.png)
ScreenPoint Medical's founders honored
Nico Karssemeijer and Sir Michael Brady honored for their notable achievements and contributions to healthcare and the sciences.
February 11, 2026
MASAI RCT: 12% reduction in interval cancer rate using Transpara
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
New research highlights Transpara Detection ‘s impact on the MASAI randomized controlled trial’s final endpoint: interval cancers.
January 30, 2026
ScreenPoint Medical and Ferrum Health partner to offer Transpara Breast AI through Ferrum’s AI Governance Suite
.png)
ScreenPoint Medical and Ferrum Health partner to offer Transpara Breast AI through Ferrum’s AI Governance Suite
Ferrum Health will offer Transpara solutions through its Model Hub, helping radiologists increase breast cancer detection and improve their workflow
January 13, 2026
Our Top 5 in 2025
.png)
Our Top 5 in 2025
ScreenPoint Medical's top news, articles, blogs, and perspective from 2025.
January 01, 2026
.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp)
.png)
.png)